The Group's principal activities are the research and development, production, sale and distribution of a series of modernised Chinese medicines and chemical medicines. Other activities include investment and property holding. The Group's major products includes Cardio-cerebral, Hepatitis, Oncology and Analgesic medicines. The Group's main operations are in the People's Republic of China.
Alacra Alerts:
Receive alerts on the latest reports on Sino Biopharmaceutical Ltd
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
